Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.
Jessica C PetrovAakash A DesaiGursimran S KochharSheena K CrosbyJami A KinnucanMichael F PiccoJana G HashashFrancis A FarrayePublished in: Inflammatory bowel diseases (2024)
Patients with IBD and T2DM on metformin had a decreased likelihood of worse IBD outcomes.